Home
Perseid Therapeutics

Perseid Therapeutics Market Share Analysis for June 2026

Astellas is a global life sciences company turning science into value for patients through transformative therapies. Discover how we're pioneering new healthcare solutions.

Health > Biotechnology and Pharmaceuticals

Domainastellas.us

Year Founded--

Employees5001 - 10000

Annual Revenue--

Perseid Therapeutics

Perseid Therapeutics (including company regionals)

astellas.us

See more website traffic and engagement information

Total visits to Perseid Therapeutics's top domains

Understand Perseid Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

astellas.us11.4K

See more with Sales Intelligence

Avg. visit duration in Perseid Therapeutics's top domains

Analyze Perseid Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

astellas.us00:01:08

See more with Sales Intelligence

Avg. pageviews on Perseid Therapeutics's top domains

See how Perseid Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

astellas.us1.44

See more with Sales Intelligence

Perseid Therapeutics top competitors by domain

Top similar sites in June 2026, ranked by their affinity

myrbetriq.comCompany NameMyrbetriqEmployees51 - 200HQUnited States, Illinois, NorthbrookAnnual revenue$5M - $10MTotal visits18.3KHealth > Health - Other

Top technologies used by Perseid Therapeutics

These are the website technologies, by industry, used by Perseid Therapeutics top domains

Advertising (8)

DoubleClick

Conversion & Analytics (7)

Google Analytics

Content Management System (3)

Drupal

Marketing (3)

Google Marketing Platform

More Technologies

10

See all

News & Signals from Perseid Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAstellas closed offices in Eccles, United Kingdom, Northern Europe, Europe on Sep 9th '24.More recently, Astellas Gene Therapies decided to close its Eccles biomanufacturing facility in South San Francisco in an unrelated move expected to impact around 100 employees.

NewsAstellas is developing platform aimed at linking early-stage research.Although no financial details were disclosed, Astellas and Yaskawa said they will initiate discussions to develop a new platform aimed at linking early-stage research to commercialization and reducing the R&D time of cell therapy.